IL153079A0 - Neuroprotective peptides - Google Patents
Neuroprotective peptidesInfo
- Publication number
- IL153079A0 IL153079A0 IL15307901A IL15307901A IL153079A0 IL 153079 A0 IL153079 A0 IL 153079A0 IL 15307901 A IL15307901 A IL 15307901A IL 15307901 A IL15307901 A IL 15307901A IL 153079 A0 IL153079 A0 IL 153079A0
- Authority
- IL
- Israel
- Prior art keywords
- neuroprotective peptides
- neuroprotective
- peptides
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/505—Erythropoietin [EPO]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US20765400P | 2000-05-26 | 2000-05-26 | |
PCT/US2001/016654 WO2001091780A1 (en) | 2000-05-26 | 2001-05-23 | Neuroprotective peptides |
Publications (1)
Publication Number | Publication Date |
---|---|
IL153079A0 true IL153079A0 (en) | 2003-06-24 |
Family
ID=22771463
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL15307901A IL153079A0 (en) | 2000-05-26 | 2001-05-23 | Neuroprotective peptides |
Country Status (12)
Country | Link |
---|---|
EP (1) | EP1296702A4 (en) |
JP (1) | JP2003534384A (en) |
CN (1) | CN1318084C (en) |
AU (2) | AU7490401A (en) |
BR (1) | BR0111182A (en) |
CA (1) | CA2410453A1 (en) |
HK (1) | HK1058484A1 (en) |
IL (1) | IL153079A0 (en) |
MX (1) | MXPA02011727A (en) |
NZ (1) | NZ522924A (en) |
WO (1) | WO2001091780A1 (en) |
ZA (1) | ZA200210304B (en) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL146798A0 (en) | 1999-06-14 | 2002-07-25 | Genentech Inc | A structured peptide scaffold for displaying turn libraries on phage |
US20030166003A1 (en) * | 1999-06-14 | 2003-09-04 | Cochran Andrea G. | Structured peptide scaffold for displaying turn libraries on phage |
US7078376B1 (en) | 2000-08-11 | 2006-07-18 | Baxter Healthcare S.A. | Therapeutic methods for treating subjects with a recombinant erythropoietin having high activity and reduced side effects |
US6914123B2 (en) | 2001-04-17 | 2005-07-05 | Genentech, Inc. | Hairpin peptides with a novel structural motif and methods relating thereto |
TWI353991B (en) | 2003-05-06 | 2011-12-11 | Syntonix Pharmaceuticals Inc | Immunoglobulin chimeric monomer-dimer hybrids |
WO2004101740A2 (en) | 2003-05-06 | 2004-11-25 | Syntonix Pharmaceuticals, Inc. | Clotting factor-fc chimeric proteins to treat hemophilia |
US7348004B2 (en) | 2003-05-06 | 2008-03-25 | Syntonix Pharmaceuticals, Inc. | Immunoglobulin chimeric monomer-dimer hybrids |
MXPA05012315A (en) | 2003-05-12 | 2006-04-18 | Affymax Inc | Novel poly(ethylene glycol) modified compounds and uses thereof. |
CN1823088B (en) | 2003-05-12 | 2011-04-13 | 阿费麦克斯公司 | Novel peptides that bind to the erythropoietin receptor |
DE602004020610D1 (en) | 2003-05-12 | 2009-05-28 | Affymax Inc | NEW PEPTIDE BINDING TO THE ERYTHROPOIETIN RECEPTOR |
EP2204193A3 (en) * | 2003-05-12 | 2010-08-18 | Affymax, Inc. | Novel spacer moiety for poly(ethylene glycol)-modified peptide-based compounds |
US7589063B2 (en) | 2004-12-14 | 2009-09-15 | Aplagen Gmbh | Molecules which promote hematopoiesis |
US7714114B2 (en) | 2005-02-16 | 2010-05-11 | Nektar Therapeutics | Conjugates of an EPO moiety and a polymer |
US7550433B2 (en) | 2005-06-03 | 2009-06-23 | Affymax, Inc. | Erythropoietin receptor peptide formulations and uses |
EP1857463A1 (en) * | 2006-05-03 | 2007-11-21 | Ebewe Pharma Ges.m.b.H. Nfg. KG | Peptide having neuroprotective effects |
EP2275142A3 (en) | 2006-06-30 | 2011-05-11 | Andre Koltermann | Conjugates for immunotherapy of cancer |
WO2008095004A2 (en) | 2007-01-31 | 2008-08-07 | Affymax, Inc. | Nitrogen-based linkers for attaching modifying groups to polypeptides and other macromolecules |
EP2018835B1 (en) | 2007-07-09 | 2014-03-05 | Augustinus Bader | Agent-eluting plaster |
EP3100745B1 (en) | 2009-02-05 | 2018-04-18 | Immunogen, Inc. | Novel benzodiazepine derivatives |
RU2410392C2 (en) * | 2009-02-16 | 2011-01-27 | Учреждение Российской академии медицинских наук Научно-исследовательский институт фармакологии имени В.В. Закусова РАМН | Dipeptide mimetics of ngf and bdnf neurotrophins |
EP2590666B1 (en) | 2010-07-06 | 2017-04-26 | Augustinus Bader | Topical application of erythropoietin for use in the treatment of injuries of the cornea |
KR20140010067A (en) | 2011-02-15 | 2014-01-23 | 이뮤노젠 아이엔씨 | Methods of preparation of conjugates |
CN105517561A (en) * | 2013-07-17 | 2016-04-20 | 阿拉伊姆药品公司 | Tissue protective peptides and peptide analogs for preventing and treating diseases and disorders associated with tissue damage |
CN105017406B (en) * | 2014-04-21 | 2020-10-09 | 上海市第一人民医院 | Novel polypeptide with neuroprotective function |
CN105233256A (en) * | 2015-10-28 | 2016-01-13 | 中国人民解放军第三军医大学 | Application of erythropoietin and erythropoietin derivatives to preparation of medicine for promoting apoptotic cell clearance during disease treatment |
GB201609083D0 (en) | 2016-05-24 | 2016-07-06 | Syntab Therapeutics Gmbh | Synthetic compound |
JP7445978B2 (en) | 2018-09-14 | 2024-03-08 | エポメッド株式会社 | anti-erythropoietin receptor peptide |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5767078A (en) * | 1995-06-07 | 1998-06-16 | Johnson; Dana L. | Agonist peptide dimers |
US6165783A (en) * | 1997-10-24 | 2000-12-26 | Neuro Spheres Holdings Ltd. | Erythropoietin-mediated neurogenesis |
US6660843B1 (en) * | 1998-10-23 | 2003-12-09 | Amgen Inc. | Modified peptides as therapeutic agents |
-
2001
- 2001-05-23 BR BR0111182-5A patent/BR0111182A/en not_active Application Discontinuation
- 2001-05-23 CA CA002410453A patent/CA2410453A1/en not_active Abandoned
- 2001-05-23 MX MXPA02011727A patent/MXPA02011727A/en unknown
- 2001-05-23 IL IL15307901A patent/IL153079A0/en unknown
- 2001-05-23 JP JP2001587795A patent/JP2003534384A/en active Pending
- 2001-05-23 EP EP01941562A patent/EP1296702A4/en not_active Withdrawn
- 2001-05-23 WO PCT/US2001/016654 patent/WO2001091780A1/en active IP Right Grant
- 2001-05-23 AU AU7490401A patent/AU7490401A/en active Pending
- 2001-05-23 CN CNB018131794A patent/CN1318084C/en not_active Expired - Fee Related
- 2001-05-23 AU AU2001274904A patent/AU2001274904B2/en not_active Ceased
- 2001-05-23 NZ NZ52292401A patent/NZ522924A/en not_active IP Right Cessation
-
2002
- 2002-12-19 ZA ZA200210304A patent/ZA200210304B/en unknown
-
2004
- 2004-02-25 HK HK04101352A patent/HK1058484A1/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CA2410453A1 (en) | 2001-12-06 |
NZ522924A (en) | 2004-12-24 |
CN1452492A (en) | 2003-10-29 |
JP2003534384A (en) | 2003-11-18 |
ZA200210304B (en) | 2004-03-19 |
CN1318084C (en) | 2007-05-30 |
EP1296702A4 (en) | 2005-05-11 |
AU7490401A (en) | 2001-12-11 |
EP1296702A1 (en) | 2003-04-02 |
MXPA02011727A (en) | 2003-10-24 |
HK1058484A1 (en) | 2004-05-21 |
BR0111182A (en) | 2004-02-25 |
AU2001274904B2 (en) | 2006-08-31 |
WO2001091780A1 (en) | 2001-12-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NZ522924A (en) | Neuroprotective peptides | |
GB0014870D0 (en) | Peptides | |
IL146832A0 (en) | Peptides | |
SI1294381T1 (en) | Neuroprotective 7-beta-hydroxysteroids | |
GB0029777D0 (en) | Peptides | |
AU6268901A (en) | Oligopeptides | |
EP1147130A4 (en) | Alpha-conotoxin peptides | |
EP1159288A4 (en) | Alpha-conotoxin peptides | |
GB0001825D0 (en) | Peptides | |
IL144376A0 (en) | Peptides | |
GB0007263D0 (en) | Peptides | |
EP1151100A4 (en) | Tau-conotoxin peptides | |
EP1323731A4 (en) | Novel peptides | |
GB0018307D0 (en) | Polypeptides | |
GB0007264D0 (en) | Peptides | |
GB0010327D0 (en) | Peptides | |
GB0001826D0 (en) | Peptides | |
GB0021475D0 (en) | Anti-aniogenic peptides | |
GB9928325D0 (en) | Peptides | |
GB9907911D0 (en) | Peptides | |
TJ20000630A (en) | Photosensetive material | |
GB0029850D0 (en) | Modifying material | |
GB0017431D0 (en) | Novel peptide sequence | |
GB0021877D0 (en) | Novel peptide sequence | |
GB0117737D0 (en) | Modified peptides |